On the other hand, CLEC12A enhances the IFN response following viral infection, thereby enhancing the antiviral immune response, which is diminished and delayed in patients with COVID-19 and is only observed in patients developing critical illness12,27. The gene discussed is CLEC12A; the disease is COVID-19.